CELU vs REGN: Which Stock is Better?
Side-by-side comparison of Celularity Inc and Regeneron Pharmaceuticals Inc in 2026
CELU
Celularity Inc
—
REGN
Regeneron Pharmaceuticals Inc
$677.53
Key Metrics Comparison
| Metric | CELU | REGN | Winner |
|---|---|---|---|
| Market Cap | $25.25M | $59.10B | REGN |
| P/E Ratio | N/A | 13.91 | REGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze CELU
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CELU or REGN a better investment?
Comparing CELU and REGN: Celularity Inc has a market cap of $25.25M while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CELU and REGN?
CELU (Celularity Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CELU or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CELU or REGN?
Both CELU and REGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: CELU or REGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: CELU or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $25.25M for CELU.
Should I buy CELU or REGN in 2026?
Both CELU and REGN have investment merit. CELU trades at $N/A while REGN trades at $677.53. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CELU and REGN stock?
Key differences: Market Cap ($25.25M vs $59.10B), P/E Ratio (N/A vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy CELU or REGN in 2026?
The choice between CELU and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between CELU and REGN?
CELU (Celularity Inc) has a market cap of $25.25M, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.